FindTrial
Sign In

A real-world study on the establishment of a prognostic model and prospective validation of hepatocellular carcinoma patients receiving vascular interventional therapy based on multimodal data structure and deep learning algorithm

A real-world study on the establishment of a prognostic model and prospective validation of hepatocellular carcinoma patients receiving vascular interventional therapy based on multimodal data structure and deep learning algorithm

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057447
Enrollment
Unknown
Registered
2022-03-12
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

1:none

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pathological or clinical diagnosis of hepatocellular carcinoma; 2. He has not received vascular interventional therapy before; 3. Liver MRI or CT imaging examination was performed before and after the treatment; 4. The scheme of vascular interventional therapy is FOLFOX; 5. Corresponding laboratory examination and baseline data before this treatment.

Exclusion criteria

Exclusion criteria: 1. Refusing to participate in the study; 2. Too many missing values.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
objective response rate;progression-freesurvival;safety;—

Countries

China

Contacts

Public ContactKai Zhang

Tianjin Medical University Cancer Institute and Hospital

zhangkaicr@foxmail.com+86 18502623020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026